-
Nature: Scientists question the transparency and reproducibleness of AI technology!
Time of Update: 2020-11-02
Oct 19, 2020 // -- In a recent study published in the international journal Nature, scientists from the City University of New York and others challenged the use of artificial intelligence systems for
-
PNAS: The world's first discovery! Some microorganisms may change their evolutionary rules through horizontal gene transfer!
Time of Update: 2020-11-02
October 19, 2020 // -- In a recent study published in the international journal PNAS, scientists from Monash University and others discovered for the first time in the world that certain microorganism
-
Science Sub-Journal: Protective antibodies can last for months in survivors of severe infection with the new coronavirus
Time of Update: 2020-11-02
study was published in the October 8, 2020 issue of the journal Science Immunology under the title "Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 Spike protein in COVID-19 patients." images from Science Immunology, 2020, doi:10.1126/sciimmunol.abe0367.
-
Nat Commun: Research promotes the development of COVID19 drugs
Time of Update: 2020-11-02
Oct 9, 2020 /---Xinthough, according to a new study recently published in the journal Nature Communications, scientists describe ways to quickly design improved and more effective compounds that work against COVID-19.
-
Nat Biomed Engine: The fusion therapy of blood protein and immunosuppressive cytokines may be available to treat multiple sclerosis
Time of Update: 2020-11-02
19, 2020 // -- Multiple sclerosis is an autoimmune disease of the central nervous system that affects millions of people around the world and can seriously affect the quality of daily life of patients
-
Nat Genet: Single-gene disease may not be as simple as scientists think
Time of Update: 2020-11-02
When the researchers analyzed all known BBS genes in these patients, they found that they carried more than three times as many additional mutations, patterns that more easily linked researchers to genetic disorders with complex characteristics, such as Alzheimer's disease and type 2 diabetes.
-
Science Sub-Journal: New coronavirus antibodies can last at least three months after infection
Time of Update: 2020-11-02
study was published in the October 8, 2020 issue of the journal Science Immunology under the title "Persistence of serum and saliva antibody responses to SARS-CoV-2 Spike antigens in COVID-19 patients." images from Science Immunology, 2020, doi:10.1126/sciimmunol.abe5511.
-
Science Sub-Journal: The fusion of cytokines and antibodies promises to treat glioblastoma
Time of Update: 2020-11-02
17, 2020 /--- In a new study, researchers from the University of Zurich, the Federal Institute of Technology zurich, the University Hospital of Zurich and the biotechnology company Philochem have found that fusing cytokines with antibodies is an effective treatment for glioblastoma in mice.
-
Sci Adv: What's new! Scientists have identified a new type of virus called molecular scissorsase from SARS-CoV-2 or a special target for the development of new targeted therapies!
Time of Update: 2020-11-01
21, 2020 // -- In a recent study published in the international journal Science Advances, scientists from the University of Texas Center for Health Sciences and others developed a new drug design idea for COVID-19, a key "molecular scissors" that block viruses, a key tool used by viruses to replicate and promote protein invigoration that is important for human immune response.
-
Prevention of respiratory infections Injection card seedlings are also useful! The results of clinical trials are published in Cell
Time of Update: 2020-11-01
in the latest issue of Cell, a leading academic journal, the results of a clinical trial showed that caesody can also benefit older people with low immunity and prevent multiple respiratory infections safely and effectively.
-
Clin Cancer Res: A special new tool is expected to help fight melanoma
Time of Update: 2020-11-01
21, 2020 // -- In a recent study published in the international journal Clinical Cancer Research, scientists from the University of Idiscovin and others found a key blood marker for cancer that could help scientists choose the most effective melanoma treatment, and the results may help improve survival rates in melanoma patients.
-
Blood Adv: Use blood type or hopefully help predict an individual's risk of contracting severe COVID-19
Time of Update: 2020-11-01
in a second study, researchers included 95 patients hospitalized in Canada with severe COVID-19, and found that patients with type A and AB blood may be more likely to need mechanical ventilation to breathe, suggesting a higher risk of lung damage from COVID-19 infections.
-
Science Read! How do neutral granulocytes enhance the body's susceptible to respiratory syncytial viruses?
Time of Update: 2020-11-01
October 21, 2020 // -- Having more bacteria-resistant immune cells in the nasal cavity and throat may help explain why some people are more likely to be infected with respiratory viruses in their ski
-
New drug for psoriasis arthritis (PsA)! Johnson il-23 inhibitor Tremfya (Tenoya ®) recommended by the European Union CHMP approval, China has been listed!
Time of Update: 2020-11-01
in the European Union, Tremfya was first approved in November 2017 to treat adult patients with moderate to severe plaque psoriasis suitable for systemic therapy.
clinical studies have shown that Tremfya significantly improves the joints, skin, soft tissue symptoms and signs of active PSA patients compared to placebos.
-
Sci Immunol: What's new! Natural killer cells may also have immune memory!
Time of Update: 2020-11-01
21, 2020 // -- In a recent study published in the international journal Science Immunology, scientists from the Medical University of Vienna and other institutions found that a sub-group of cytotoxic
-
Nat Commun: What's new! Scientists identify specific protein molecules that can promote cancer and progress!
Time of Update: 2020-11-01
October 21, 2020 // -- The occurrence of cancer is a highly complex process that involves multiple genes and signaling path path paths that are in an upward or downward state at different stages of ca
-
Redsiway may not help treat COVID-19 patients, new WHO study finds
Time of Update: 2020-11-01
WHO's study only tested the effectiveness of Redsiway's treatment for 10 days, so some patients may have spent longer in hospital than they needed to complete the treatment, which would make their stay look similar to that of other people who received day-to-day care; () References: 1 WHO study finds remdesivir didn't't help COVID-19 patients 2 repurposed antiviral drugs for COVID-19 -interim WHO SOLIDARITY trial results s 3" Remdesivir for Treatment of Covid-19 - Final Report
-
There are five things you need to do to protect your gut health
Time of Update: 2020-11-01
, according to Dr. Sal Bakkali-Derksen of Mayo Clinic Health System, "Studies have shown that Western diets are associated with a higher incidence of colon cancer.
Q&A: Preventing colon cancer with screening, early detection
-
How does the weather affect the severity of joint and muscle soreness?
Time of Update: 2020-11-01
recent studies have shown an increase in overall pain trends in older men and women, with a significant increase in the correlation between joint pain and weather conditions in patients with rheumatoid arthritis or osteoarthritis.
-
Yale experts explain "group immunity": What does it mean to control the new crown outbreak? What factors affect the effect?
Time of Update: 2020-10-31
The global pandemic of the new crown outbreak, herd immunity, is once again in the public eye and under sustained attention. fact, it is not the first time that mass immunization has emerged in the l
